Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2013
12/25/2013EP2675806A1 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
12/25/2013EP2675481A1 Cytotoxic benzodiazepine derivatives and methods of preparation
12/25/2013EP2675480A1 Methods of preparation of conjugates
12/25/2013EP2675479A1 Cytotoxic benzodiazepine derivatives
12/25/2013EP2516442B1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
12/25/2013EP2455371B1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
12/25/2013EP2414365B1 SUBSTITUTED [1,2,4¨TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
12/25/2013EP2391627B1 Bicyclic pyrazolo-heterocycles
12/25/2013EP2132167B1 METHOD FOR THE PRODUCTION OF beta-KETONITRILES
12/25/2013CN103476778A Novel salts of DPP-IV inhibitor
12/25/2013CN103476777A Novel heterocyclic derivatives
12/25/2013CN103476776A 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors
12/25/2013CN103476775A Flinderole analogues and process for synthesis thereof
12/25/2013CN103476774A Materials for electronic devices
12/25/2013CN103476773A New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/25/2013CN103476768A 6,5-heterocyclic propargylic alcohol compounds and uses therefor
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103467471A Organic compounds
12/25/2013CN103467470A Ocycloimino sugar compound and intermediate, medicament, preparation method and application thereof
12/25/2013CN103467450A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103467447A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103464212A Acid-binding composite catalyst and preparation method and application thereof
12/25/2013CN103122000B High-selectivity c-Met kinase inhibitor used as antitumor drug
12/25/2013CN102470136B PLK inhibitor salts
12/25/2013CN102015702B Cyclic ethers
12/24/2013US8614229 Substituted indole derivatives and methods of use thereof
12/24/2013US8614218 Fused bicyclic pyrimidines
12/24/2013CA2617096C Macrocyclic inhibitors of hepatitis c virus
12/24/2013CA2613059C Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments
12/24/2013CA2597608C Pyrazolo-pyrimidine derivatives as mglur2 antagonists
12/19/2013WO2013188856A1 Imidazopyrazine syk inhibitors
12/19/2013WO2013188838A2 Storage, retrieval, analysis, pricing, and marketing of personal health care data using social networks, expert networks, and markets
12/19/2013WO2013188783A1 Deuterated derivatives of ruxolitinib
12/19/2013WO2013186326A1 NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ß-AMINOBUTYRYL SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,4]DIAZOLO[4,3-alpha]PYRAZIN-7-YL COMPOUNDS
12/19/2013WO2013186159A1 New diazaspirocycloalkane and azaspirocycloalkane
12/19/2013WO2013185464A1 Filter tip additive for reducing nitrosamine in cigarette smoke and use thereof
12/19/2013US20130338173 Carbocycle-Substituted Purine And 7-Deazapurine Compounds
12/19/2013US20130338172 Crystalline forms of a bruton's tyrosine kinase inhibitor
12/19/2013US20130338171 Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
12/19/2013US20130338157 Azaindazole compounds and methods of use
12/19/2013US20130338156 Imidazopyridin-2-one derivatives
12/19/2013US20130338153 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
12/19/2013US20130338152 Fluorophenyl bicyclic heteroaryl compounds
12/19/2013US20130338148 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
12/19/2013US20130338142 Imidazopyrazine syk inhibitors
12/19/2013US20130338141 Hiv integrase inhibitors
12/19/2013US20130338139 Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-ones
12/19/2013US20130338137 Substituted annellated pyrimidines and use thereof
12/19/2013US20130338133 Substituted imidazopyridazines
12/19/2013US20130338124 Organic compounds
12/19/2013US20130338104 3-Substituted-4-Oxo-3,4-Dihydro-Imidazo[5,1-d]1,2,3,5-Tetrazine-8-Carboxylic Acid Amides and Their Use
12/19/2013CA2876306A1 Deuterated derivatives of ruxolitinib
12/18/2013EP2674434A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators
12/18/2013EP2674433A1 LIMK2 inhibitors, compositions comprising them and methods of their use
12/18/2013EP2674432A1 New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds
12/18/2013EP2673277A1 [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
12/18/2013EP2673276A1 Flinderole analogues and process for synthesis thereof
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013EP2475650B1 Furan derivative and electrophotographic photoconductor
12/18/2013EP2392574B1 Indolyl pyrrolidines for the treatment of cancer
12/18/2013EP2374807B1 An improved process for the isolation of temozolomide
12/18/2013EP1855529B1 Spiroketal-substituted cyclic ketoenols
12/18/2013EP1782800B1 Methods for detecting JAK3 inhibitors
12/18/2013CN103459399A Tetracyclic indole derivatives for treating hepatitis c virus infection
12/18/2013CN103459397A 6-cyclobutyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as PDE9A inhibitors
12/18/2013CN103459396A [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of c-met tyrosine kinase
12/18/2013CN103459395A (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
12/18/2013CN103459394A Crystalline and non-crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer
12/18/2013CN103459393A Preparation of bicyclic guanidine salts in an aqueous media
12/18/2013CN103459392A Process for the production of a pemetrexed salt
12/18/2013CN103459391A Compounds for electronic devices
12/18/2013CN103450218A Indole tricyclic derivative as CRTH2 receptor antagonist
12/18/2013CN103450205A Preparation method and application of fluorescent probe based on polydentate pyridine quinoxaline
12/18/2013CN103450204A Pyrrole [2,1-f][1,2,4] triazine compound, and preparation method and purpose thereof
12/18/2013CN103450172A Preparation method of antipsychotic drug lurasidone
12/18/2013CN103449947A Pre-purification method before sublimation and purification of OLED (organic light emitting diode) material
12/18/2013CN102307949B Novel azomethine compound and thermal transfer sheet using coloring matter of azomethine compound
12/18/2013CN102285992B Dihydroporphin (III) chelates having plant growth regulating activity and use thereof as plant growth regulator
12/18/2013CN102216305B Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes
12/18/2013CN101657420B Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediate
12/17/2013US8609867 Substituted indolocarbazoles
12/17/2013US8609861 Hexaaza [3.3.3] propellane compounds as key intermediates for new molecular explosives and a method for preparing the same
12/17/2013US8609837 Metallation enhancements in tumor-imaging and PDT therapy
12/17/2013US8609669 Potassium channel modulators
12/17/2013US8609668 Substituted triazolo[1,5-A]pyrimidines as antiviral agents
12/17/2013US8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases
12/17/2013US8609660 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
12/17/2013US8609647 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof
12/17/2013US8609259 Organic electroluminescent device and platinum compound
12/17/2013CA2754154C Method for the industrial purification of biologically active phycotoxins
12/17/2013CA2733533C Hedgehog pathway modulators
12/17/2013CA2637388C Pyrrolopyridazinone compound
12/12/2013WO2013185103A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013WO2013185093A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013WO2013185090A1 Macrocyclic inhibitors of flaviviridae viruses
12/12/2013WO2013184985A1 Inhibitors of influenza viruses replication
12/12/2013WO2013183578A1 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVE AS KINASE INHIBITOR
12/12/2013WO2013182612A1 Glucose transport inhibitors
12/12/2013WO2013182580A1 Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
12/12/2013WO2013182546A1 Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 573